Clinical Trial Update: Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA

View source ↗

Summary

A University of Ulm-led study is investigating epigenetic imprinting in gestational diabetes by analyzing cell-free DNA, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: University of Ulm | Conditions: Gestational Diabetes Mellitus (GDM) | Status: RECRUITING